4.3 Article

Morphine decreases early peritoneal innate immunity responses in Swiss-Webster and C57BL6/J mice through the inhibition of mast cell TNF-α release

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 232, Issue 1-2, Pages 101-107

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2010.10.017

Keywords

Morphine; TNF-alpha; CCL2; Mast cells; Endotoxemia; Antinociception

Funding

  1. Conacyt [39726, 200394]

Ask authors/readers for more resources

Objective: To characterize immunosuppressive effects of morphine on the early innate immunity response of cytokine production in peritoneal cavity after LPS challenge. Methods: The effects of a single i.p. administration of morphine (3.1 or 31 mg/kg) on LPS-induced tumor necrosis factor alpha (TNF-alpha) and monocyte chemoattractant protein-1 (CCL2) intraperitoneal release was tested in Swiss-Webster, C57BL/6J, mast cell deficient Kit (Wsh/Wsh) (W-sh) and mast cell reconstituted (W-sh-rec) mice. Results: Morphine was found to inhibit LPS-induced TNF-alpha but not CCL2 release in the peritoneal cavity. Studies on mast cell deficient and reconstituted mice indicate that resident mast cells mediate selective morphine immunosuppression in the peritoneal cavity. (C) 2010 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available